|
|
 |
| |
|
Home > Drug Companies > Serono Inc.
Serono Inc.
A drug manufacturer is a business entity engaged in making, assembling, processing or modifying devices, or mixing, producing or preparing drugs in dosage forms by encapsulating, entableting or other process, or packaging, repackaging or otherwise changing the container, wrapper or label of any package containing a drug or device in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer.
As the US affiliate of Serono S.A., a global biotechnology leader headquartered in Geneva, Switzerland. Serono, Inc. is an integral part of driving the growth and success of the company's global business. As a leading U.S. biotechnology company, Serono, Inc. is committed to discovering and developing medicines that address significant unmet medical needs. Serono has built its reputation as a leader in the industry by integrating cutting edge science with comprehensive patient support systems to improve people's lives.
Developing new therapies for patients with unmet medical needs is their focus at Serono, Inc., with seven major biotechnology products on the market across three therapeutic areas, as well as several other commercial products. At Serono, they believe that providing patients with support, resources and information is an important part of treating disease. They have an ongoing commitment to improving the patient experience by offering patient friendly delivery systems as well as comprehensive patient education resources across all therapeutic areas.
At Serono, their focus is on meeting significant unmet medical needs and helping people live fuller and more satisfying lives. Through groundbreaking science and comprehensive patient support systems, Serono offers patients a continuum of products and services. They are committed to enhancing the patient experience by providing the necessary resources and information and partnering with patients throughout their treatment.
Back to Drug Companies
|
|
|
|
|
|
|
|